Literature DB >> 17045344

Lipopolysaccharide and cyclic AMP regulation of CB(2) cannabinoid receptor levels in rat brain and mouse RAW 264.7 macrophages.

Somnath Mukhopadhyay1, Sucharita Das, Evelyn A Williams, Duane Moore, Jenelle D Jones, Daniel S Zahm, Michael M Ndengele, Andrew J Lechner, Allyn C Howlett.   

Abstract

CB(2) cannabinoid receptors exist in immune cells including macrophages. Affinity-purified antibodies against the CB(2) receptor identified a 45 kDa protein in rat brain, human tonsil and rat and mouse microglia, but not mouse N18TG2 neuroblastoma cells. Intracerebroventricular lipopolysaccharide (LPS) increased immunoreactive CB(2) receptors in brain membranes detected by Western blot. LPS increased immunodetectable CB(2) receptors in cultured RAW 264.7 macrophages, and this was partially attenuated by cyclohexamide or the protein kinase A and C inhibitors H8 and bis-indolylmaleimide. Forskolin or dibutyryl cyclic AMP increased CB(2) receptor immunoreactivity, suggesting the involvement of the cyclic AMP-protein kinase A-Cyclic AMP response element pathway in the regulation of CB(2) receptor levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17045344     DOI: 10.1016/j.jneuroim.2006.08.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  25 in total

1.  Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.

Authors:  Stefania Merighi; Stefania Gessi; Katia Varani; Carolina Simioni; Debora Fazzi; Prisco Mirandola; Pier Andrea Borea
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.

Authors:  D Fernández-López; J Faustino; N Derugin; M Wendland; I Lizasoain; M A Moro; Z S Vexler
Journal:  Neuroscience       Date:  2012-01-12       Impact factor: 3.590

Review 3.  Cannabinoids as therapeutic agents for ablating neuroinflammatory disease.

Authors:  G A Cabral; L Griffin-Thomas
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-09       Impact factor: 2.895

Review 4.  Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease.

Authors:  Sreemanti Basu; Bonnie N Dittel
Journal:  Immunol Res       Date:  2011-10       Impact factor: 2.829

5.  Marine cyanobacterial fatty acid amides acting on cannabinoid receptors.

Authors:  Rana Montaser; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2012-11-09       Impact factor: 3.164

6.  Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.

Authors:  Mohamed Naguib; Jijun J Xu; Philippe Diaz; David L Brown; David Cogdell; Bihua Bie; Jianhua Hu; Suzanne Craig; Walter N Hittelman
Journal:  Anesth Analg       Date:  2012-03-05       Impact factor: 5.108

7.  Mutant huntingtin impairs immune cell migration in Huntington disease.

Authors:  Wanda Kwan; Ulrike Träger; Dimitrios Davalos; Austin Chou; Jill Bouchard; Ralph Andre; Aaron Miller; Andreas Weiss; Flaviano Giorgini; Christine Cheah; Thomas Möller; Nephi Stella; Katerina Akassoglou; Sarah J Tabrizi; Paul J Muchowski
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

8.  Cannabinoid CB1 and CB2 Receptors, and Monoacylglycerol Lipase Gene Expression Alterations in the Basal Ganglia of Patients with Parkinson's Disease.

Authors:  Francisco Navarrete; M Salud García-Gutiérrez; Auxiliadora Aracil-Fernández; José L Lanciego; Jorge Manzanares
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

9.  The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration.

Authors:  John C Ashton; Michelle Glass
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

10.  Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats.

Authors:  Marnie Duncan; Abdeslam Mouihate; Ken Mackie; Catherine M Keenan; Nancy E Buckley; Joseph S Davison; Kamala D Patel; Quentin J Pittman; Keith A Sharkey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-15       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.